Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators
Background. Emerging evidence suggests that nonalcoholic fatty liver disease (NAFLD) is associated with coronary artery diseases and arrhythmias. The FibroScan (Echosens, France), a widely available, noninvasive device, is able to detect liver fibrosis and steatosis within this patient population. H...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | Inglês |
| 出版: |
Wiley
2017-01-01
|
| 丛编: | Canadian Journal of Gastroenterology and Hepatology |
| 在线阅读: | http://dx.doi.org/10.1155/2017/7298032 |
| 标签: |
没有标签, 成为第一个标记此记录!
|